Home  >  Press Releases  >  Products & Services
Share

Press Releases

Press release year list 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
January 4, 2022
Simparica Trio proven to block the pathogen that causes Lyme disease by killing deer ticks PARSIPPANY, N.J. –January 4, 2022– Zoetis today announced that the U.S. Food and Drug Administration (FDA) has approved a new label indication for Simparica Trio ® (sarolaner, moxidectin, and pyrantel chewable tablets) for the prevention of Borrelia burgdorferi infections as a direct result of killing Ixodes scapularis vector ticks (black-legged or deer ticks).  Simparica Trio is approved for dogs eight weeks of age and older weighing 2.8 pounds and greater. Simparica Trio is the first and only combination product demonstrated to prevent infections that may cause Lyme disease by killing deer or black-legged ticks. “Tick-borne diseases are a serious threat to pets and Lyme disease, caused by Borrelia burgdorferi , is transmitted by deer ticks. It is critical to have easily accessible and effective options for preventing infections available to protect dogs from ticks so ...